U.S. investors cut their use of leverage in July, marking the first month since the onset of the pandemic that saw a reduction in the use of margin debt to buy securities like stocks, potentially a warning sign for markets buoyed by heavy use of borrowed money.
In 2019, still settling into his new home in the state’s creepy, gothic governor’s mansion, Gavin Newsom told an Axios interviewer, “California is what America is going to look like.” Then, perhaps reflecting on his Hollywood benefactors, he added for emphasis, “California is America’s coming attraction.”
The appeals court said Monsanto had not shown that federal law preempted claims made by plaintiffs Alva and Alberta Pilliod, who in 2019 were awarded a combined $87 million after lawyers argued years of using Roundup weedkiller caused them both to develop non-Hodgkin lymphoma.
US securities regulators plan to require additional information from Chinese companies seeking to go public on American exchanges, saying the move will protect domestic investors.
Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
